Research Article Details

Article ID: A42414
PMID: 34600840
Source: J Clin Lipidol
Title: Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome.
Abstract: We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.
DOI: 10.1016/j.jacl.2021.09.002